Francesco Bertoni
Francesco Bertoni
IOR Institute of Oncology Research, Bellinzona, Switzerland
Verified email at ior.iosi.ch
TitleCited byYear
Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1–polarizing program in dendritic cells
G Napolitani, A Rinaldi, F Bertoni, F Sallusto, A Lanzavecchia
Nature immunology 6 (8), 769, 2005
11652005
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
M Compagno, WK Lim, A Grunn, SV Nandula, M Brahmachary, Q Shen, ...
Nature 459 (7247), 717, 2009
8892009
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
G Fabbri, S Rasi, D Rossi, V Trifonov, H Khiabanian, J Ma, A Grunn, ...
Journal of Experimental Medicine 208 (7), 1389-1401, 2011
5662011
Primary extranodal non-Hodgkin’s lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas
E Zucca, E Roggero, F Bertoni, F Cavalli
Skin 19, 20, 1997
4311997
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ...
Blood 121 (8), 1403-1412, 2013
3952013
Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness
D Rossi, A Bruscaggin, V Spina, S Rasi, H Khiabanian, M Messina, ...
Blood 118 (26), 6904-6908, 2011
3512011
The gastric marginal zone B-cell lymphoma of MALT type
E Zucca, F Bertoni, E Roggero, F Cavalli
Blood 96 (2), 410-419, 2000
3152000
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia
D Rossi, M Fangazio, S Rasi, T Vaisitti, S Monti, S Cresta, S Chiaretti, ...
Blood 119 (12), 2854-2862, 2012
2812012
Clinical Activity of Rituximab in Gastric Marginal Zone Non-Hodgkin's Lymphoma Resistant to or Not Eligible for Anti–Helicobacter Pylori Therapy
G Martinelli, D Laszlo, AJM Ferreri, G Pruneri, M Ponzoni, A Conconi, ...
Journal of Clinical Oncology 23 (9), 1979-1983, 2005
2592005
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
D Rossi, V Trifonov, M Fangazio, A Bruscaggin, S Rasi, V Spina, S Monti, ...
Journal of Experimental Medicine 209 (9), 1537-1551, 2012
2572012
Molecular analysis of the progression from Helicobacter pylori–associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach
E Zucca, F Bertoni, E Roggero, G Bosshard, G Cazzaniga, E Pedrinis, ...
New England Journal of Medicine 338 (12), 804-810, 1998
2531998
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
D Rossi, V Spina, C Deambrogi, S Rasi, L Laurenti, K Stamatopoulos, ...
Blood 117 (12), 3391-3401, 2011
2272011
Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma
G Pinotti, E Zucca, E Roggero, A Pascarella, F Bertoni, A Savio, E Savio, ...
Leukemia & lymphoma 26 (5-6), 527-537, 1997
2271997
Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin
E Roggero, E Zucca, C Mainetti, F Bertoni, C Valsangiacomo, E Pedrinis, ...
Human pathology 31 (2), 263-268, 2000
2182000
The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
U Novak, A Rinaldi, I Kwee, SV Nandula, PMV Rancoita, M Compagno, ...
Blood 113 (20), 4918-4921, 2009
2172009
Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma
A Rinaldi, I Kwee, M Taborelli, C Largo, S Uccella, V Martin, G Poretti, ...
British journal of haematology 132 (3), 303-316, 2006
2142006
Effect of single-agent rituximab given at the standard schedule or as prolonged treatment in patients with mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer …
M Ghielmini, SFH Schmitz, S Cogliatti, F Bertoni, U Waltzer, MF Fey, ...
Journal of clinical oncology 23 (4), 705-711, 2005
2052005
Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma
R Crescenzo, F Abate, E Lasorsa, M Gaudiano, N Chiesa, F Di Giacomo, ...
Cancer cell 27 (4), 516-532, 2015
1852015
Review _
E Zucca, E Roggero, F Bertoni, A Conconi, F Cavalli
Annals of Oncology 10, 1023-1033, 1999
1841999
Alteration of BIRC3 and multiple other NF-κB pathway genes in splenic marginal zone lymphoma
D Rossi, S Deaglio, D Dominguez-Sola, S Rasi, T Vaisitti, C Agostinelli, ...
Blood 118 (18), 4930-4934, 2011
1672011
The system can't perform the operation now. Try again later.
Articles 1–20